Mechanical Ventilation With Neurally-Adjusted Ventilatory Assist in Patients With ARDS
Acute Respiratory Distress Syndrome
About this trial
This is an interventional treatment trial for Acute Respiratory Distress Syndrome focused on measuring ARDS
Eligibility Criteria
Inclusion Criteria:
- Mechanical ventilation for more than 24 hours;
- Diagnosis of ARDS
- Clinical indication of lung protective mechanical ventilation by the ICU team;
- Presence of active inspiratory efforts for more than 6 hours
Exclusion Criteria:
- Patients under 18 years;
- Pregnant women;
- Trauma or burns of the face that hinder the passage of gastro-esophageal catheter;
- Nasal pathologies that prevent the progression of gastro-esophageal catheter;
- Ulcers of the esophagus or stomach;
- Documented esophageal varices;
- Tracheostomized patients;
- Instability of the chest wall or diaphragmatic injury;
- Hemodynamic instability, defined as the need to increase vasoactive drugs in the last two hours in order to maintain the mean arterial pressure above 60 mmHg).
Sites / Locations
- University of Sao Paulo General Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
PSV
NAVA
Patients will be ventilated with the a conventional mode of ventilation called Pressure Support Ventilation (PSV) for 15 minutes. Mechanical ventilator settings will be set to match the tidal volume applied by the ICU team, in accordance to current standard of care recommendations.
Patients will be ventilated with NAVA for 15 minutes. Nava level will be titrated prior to randomization, to deliver the same peak of airway pressure obtained with the active comparator, PSV. The resulting tidal volume should match the tidal volume applied by the ICU team, in accordance to current standard of care recommendations.